CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 Months-Reference-Cited by-同舟云学术

CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 Months

Published:2007-09 Issue:8 Volume:8 Page:488-492
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Brown William T.,Wu Xiaodong,Fayad Fahed,Fowler John F.,Amendola Beatriz E.,García Silvio,Han Hoke,de la Zerda Alberto,Bossart Elizabeth,Huang Zichong,Schwade James G.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. The effect of surgical treatment on survival from early lung cancer. Implications for screening;Flehinger;Chest,1992

2. Observation-only management of early stage, medically inoperable lung cancer: poor outcome;McGarry;Chest,2002

3. The role of radiotherapy in treatment of stage I nonsmall cell lung cancer;Qiao;Lung Cancer,2003

4. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience;Sibley;Int J Radiat Oncol Biol Phys,1998

5. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer;Narayan;Lung Cancer,2004

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer;Frontiers in Oncology;2022-04-29

2. Stereotactic Ablative Radiotherapy Using CyberKnife for Stage I Non-small-cell Lung Cancer: A Retrospective Analysis;Anticancer Research;2021-12-29

3. Development of a tracking error prediction system for the CyberKnife Synchrony Respiratory Tracking System with use of support vector regression;Medical & Biological Engineering & Computing;2021-10-15

4. A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer;Japanese Journal of Clinical Oncology;2021-09-27

5. Oncologic Outcomes of Surgery Versus SBRT for Non–Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis;Clinical Lung Cancer;2021-05